# Dose Response Study of Inhaled Ciclesonide (Glucocorticosteroid) to Patients With Persistent Asthma

> **NCT00174746** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 1145 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** AVE2635A

## Key facts

- **NCT ID:** NCT00174746
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 1145 (ACTUAL)
- **Last updated:** 2009-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00174746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00174746, "Dose Response Study of Inhaled Ciclesonide (Glucocorticosteroid) to Patients With Persistent Asthma". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00174746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*